| Patent | Date |
|---|
Cgrp Antagonist Compounds
App 20220306651 - Brown; Giles Albert ; et al. | 2022-09-29 |
Cgrp Antagonist Compounds
App 20220251110 - Brown; Giles Albert ; et al. | 2022-08-11 |
Pyrimidinone Derivatives As Cdc7 Inhibitors
App 20220079942 - Carswell; Emma L. ; et al. | 2022-03-17 |
Pyrimidinone derivatives as Cdc7 inhibitors
Grant 11,020,396 - Carswell , et al. June 1, 2 | 2021-06-01 |
Thienopyrimidine inhibitors of atypical protein kinase C
Grant 10,954,251 - Dorsey , et al. March 23, 2 | 2021-03-23 |
Preparation and uses of pyrimidinone derivatives
Grant 10,919,896 - Carswell , et al. February 16, 2 | 2021-02-16 |
Fused bicyclic 2,4-diaminopyrimidine derivative as a dual ALK and FAK inhibitor
Grant 10,632,119 - Allwein , et al. | 2020-04-28 |
Preparation And Uses Of Pyrimidinone Derivative
App 20200123157 - Carswell; Emma L. ; et al. | 2020-04-23 |
Pyrimidinone Derivatives As Cdc7 Inhibitors
App 20190336502 - Carswell; Emma L. ; et al. | 2019-11-07 |
Fused Bicyclic 2,4-Diaminopyrimidine Derivative as a Dual ALK and FAK Inhibitor
App 20190328735 - Allwein; Shawn P. ; et al. | 2019-10-31 |
Prodrugs of Chlorokynurenines
App 20190308934 - Laufer; Ralph ; et al. | 2019-10-10 |
Azaquinazoline inhibitors of atypical protein kinase C
Grant 10,414,763 - Dorsey , et al. Sept | 2019-09-17 |
Thienopyrimidine Inhibitors Of Atypical Protein Kinase C
App 20190106433 - DORSEY; Bruce D. ; et al. | 2019-04-11 |
Thienopyrimidine inhibitors of atypical protein kinase C
Grant 10,183,950 - Dorsey , et al. Ja | 2019-01-22 |
Prodrugs Of Chlorokynurenines
App 20180327351 - LAUFER; Ralph ; et al. | 2018-11-15 |
Fused bicyclic 2,4-diaminopyrimidine derivative as a dual ALK and FAK inhibitor
Grant 10,111,872 - Allwein , et al. October 30, 2 | 2018-10-30 |
Deuterated Chlorokynurenines For The Treatment Of Neuropsychiatric Disorders
App 20180305298 - OTT; Gregory R. ; et al. | 2018-10-25 |
Azaquinazoline inhibitors of Atypical protein Kinase C
Grant 9,914,730 - Breslin , et al. March 13, 2 | 2018-03-13 |
Azaquinazoline inhibitors of atypical protein kinase C
Grant 9,896,446 - Breslin , et al. February 20, 2 | 2018-02-20 |
Fused Bicyclic 2,4-diaminopyrimidine Derivative As A Dual Alk And Fak Inhibitor
App 20170173017 - Allwein; Shawn P. ; et al. | 2017-06-22 |
Thienopyrimidine Inhibitors Of Atypical Protein Kinase C
App 20170158706 - Dorsey; Bruce D. ; et al. | 2017-06-08 |
Fused bicyclic 2,4-diaminopyrimidine derivative as a dual ALK and FAK inhibitor
Grant 9,623,026 - Allwein , et al. April 18, 2 | 2017-04-18 |
Thienopyrimidine inhibitors of atypical protein kinase C
Grant 9,604,994 - Dorsey , et al. March 28, 2 | 2017-03-28 |
Macrocyclic Compounds As Alk, Fak And Jak2 Inhibitors
App 20170027948 - Breslin; Henry J. ; et al. | 2017-02-02 |
Pyrrolotriazines As Alk Inhibitors
App 20160347756 - Haltiwanger; Ralph C. ; et al. | 2016-12-01 |
Macrocyclic compounds as ALK, FAK and JAK2 inhibitors
Grant 9,487,529 - Breslin , et al. November 8, 2 | 2016-11-08 |
Pyrrolotriazines as ALK inhibitors
Grant 9,440,984 - Haltiwanger , et al. September 13, 2 | 2016-09-13 |
Fused Bicyclic 2,4-diaminopyrimidine Derivative As A Dual Alk And Fak Inhibitor
App 20160243119 - Allwein; Shawn P. ; et al. | 2016-08-25 |
Fused bicyclic 2,4-diaminopyrimidine derivative as a dual ALK and FAK inhibitor
Grant 9,339,502 - Allwein , et al. May 17, 2 | 2016-05-17 |
Azaquinazoline Inhibitors of Atypical Protein Kinase C
App 20160102094 - Breslin; Henry J. ; et al. | 2016-04-14 |
Pyrrolotriazines As Alk Inhibitors
App 20160068535 - Haltiwanger; Ralph C. ; et al. | 2016-03-10 |
Imidazo[4,5-b]pyridine derivatives as ALK and JAK modulators for the treatment of proliferative disorders
Grant 9,238,656 - Breslin , et al. January 19, 2 | 2016-01-19 |
Fused Bicyclic 2,4-diaminopyrimidine Derivative as a Dual ALK and FAK Inhibitor
App 20150374693 - Allwein; Shawn P. ; et al. | 2015-12-31 |
Azaquinazoline Inhibitors Of Atypical Protein Kinase C
App 20150274720 - Dorsey; Bruce D. ; et al. | 2015-10-01 |
Fused bicyclic 2,4-diaminopyrimidine derivative as a dual ALK and FAK inhibitor
Grant 9,132,128 - Allwein , et al. September 15, 2 | 2015-09-15 |
Fused Bicyclic 2,4-diaminopyrimidine Derivative as a Dual ALK and FAK Inhibitor
App 20150011561 - Allwein; Shawn P. ; et al. | 2015-01-08 |
Imidazo[4,5-b]pyridine Derivatives as ALK and JAK Modulators for the Treatment of Proliferative Disorders
App 20140350011 - Breslin; Henry J. ; et al. | 2014-11-27 |
Thienopyrimidine Inhibitors of Atypical Protein Kinase C
App 20140323435 - Dorsey; Bruce D. ; et al. | 2014-10-30 |
Azaquinazoline Inhibitors of Atypical Protein Kinase C
App 20140113882 - Breslin; Henry J. ; et al. | 2014-04-24 |
Macrocyclic Compounds as ALK, FAK and JAK2 Inhibitors
App 20140031351 - Breslin; Henry J. ; et al. | 2014-01-30 |
Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-MET inhibitors
Grant 8,552,186 - Ahmed , et al. October 8, 2 | 2013-10-08 |
Pyrrolotriazines as ALK and JAK2 inhibitors
Grant 8,471,005 - Breslin , et al. June 25, 2 | 2013-06-25 |
Fused Bicyclic Derivatives of 2,4-Diaminopyrimidine as ALK and c-MET Inhibitors
App 20120165519 - Ahmed; Gulzar ; et al. | 2012-06-28 |
Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-Met inhibitors
Grant 8,148,391 - Ahmed , et al. April 3, 2 | 2012-04-03 |
Pyrrolotriazines As Alk And Jak2 Inhibitors
App 20120028919 - Breslin; Henry J. ; et al. | 2012-02-02 |
FUSED BICYCLIC DERIVATIVES OF 2,4-DIAMINOPYRIMIDINE AS ALK AND c-MET INHIBITORS
App 20090221555 - Ahmed; Gulzar ; et al. | 2009-09-03 |
Spiro-cyclic .beta.-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-.alpha. converting enzyme (TACE)
Grant 6,962,938 - Ott , et al. November 8, 2 | 2005-11-08 |
Spiro-cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-alpha converting enzyme (TACE)
App 20040132693 - Ott, Gregory R. ; et al. | 2004-07-08 |
Cyclic hydroxamic acids as inhibitors of matrix metalloproteinases and/or TNF- .alpha. converting enzyme (TACE)
Grant 6,740,649 - Ott , et al. May 25, 2 | 2004-05-25 |
Spiro-cyclic .beta.-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-.alpha. converting enzyme (TACE)
Grant 6,720,329 - Ott , et al. April 13, 2 | 2004-04-13 |
Beta-sulfone derivatives as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE)
App 20030212056 - Duan, Jingwu ; et al. | 2003-11-13 |
Cyclic hydroxamic acids as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE)
App 20030139388 - Ott, Gregory R. ; et al. | 2003-07-24 |
Spiro-cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-alpha converting enzyme (TACE)
App 20030087882 - Ott, Gregory R. ; et al. | 2003-05-08 |
Cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-alpha
App 20020016336 - Duan, Jingwu ; et al. | 2002-02-07 |
| 